CDKN2A and ovarian carcinoma: Therefore, this study aimed to test the hypothesis that expression of cell-cycle regulatory proteins p16INK4a and pRb is significantly associated with prognosis in a large, homogeneous series of advanced-stage ovarian carcinomas receiving standardised chemotherapy after radical surgery (du Bois et al, 2003).